Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 2003;96(Suppl 43):2–10.

Atypical cystic fibrosis--diagnostic and management dilemmas.

Colin Wallis 1
PMCID: PMC1308781  PMID: 12906319

Full Text

The Full Text of this article is available as a PDF (140.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdul Wahab A., Al Thani G., Dawod S. T., Kambouris M., Al Hamed M. Heterogeneity of the cystic fibrosis phenotype in a large kindred family in Qatar with cystic fibrosis mutation (I1234V). J Trop Pediatr. 2001 Apr;47(2):110–112. doi: 10.1093/tropej/47.2.110. [DOI] [PubMed] [Google Scholar]
  2. Acton J. D., Wilmott R. W. Phenotype of CF and the effects of possible modifier genes. Paediatr Respir Rev. 2001 Dec;2(4):332–339. doi: 10.1053/prrv.2001.0168. [DOI] [PubMed] [Google Scholar]
  3. Bell S. C., Bowerman A. R., Davies C. A., Campbell I. A., Shale D. J., Elborn J. S. Nutrition in adults with cystic fibrosis. Clin Nutr. 1998 Oct;17(5):211–215. doi: 10.1016/s0261-5614(98)80061-7. [DOI] [PubMed] [Google Scholar]
  4. Bush A., Wallis C. Time to think again: cystic fibrosis is not an "all or none" disease. Pediatr Pulmonol. 2000 Aug;30(2):139–144. doi: 10.1002/1099-0496(200008)30:2<139::aid-ppul9>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  5. Choudari C. P., Lehman G. A., Sherman S. Pancreatitis and cystic fibrosis gene mutations. Gastroenterol Clin North Am. 1999 Sep;28(3):543-9, vii-viii. doi: 10.1016/s0889-8553(05)70072-8. [DOI] [PubMed] [Google Scholar]
  6. Chu C. S., Trapnell B. C., Curristin S., Cutting G. R., Crystal R. G. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet. 1993 Feb;3(2):151–156. doi: 10.1038/ng0293-151. [DOI] [PubMed] [Google Scholar]
  7. Davis P. B., Drumm M., Konstan M. W. Cystic fibrosis. Am J Respir Crit Care Med. 1996 Nov;154(5):1229–1256. doi: 10.1164/ajrccm.154.5.8912731. [DOI] [PubMed] [Google Scholar]
  8. Dodge J. A. Nutritional requirements in cystic fibrosis: a review. J Pediatr Gastroenterol Nutr. 1988;7 (Suppl 1):S8–11. doi: 10.1097/00005176-198811001-00003. [DOI] [PubMed] [Google Scholar]
  9. Dohle G. R., Veeze H. J., Overbeek S. E., van den Ouweland A. M., Halley D. J., Weber R. F., Niermeijer M. F. The complex relationships between cystic fibrosis and congenital bilateral absence of the vas deferens: clinical, electrophysiological and genetic data. Hum Reprod. 1999 Feb;14(2):371–374. doi: 10.1093/humrep/14.2.371. [DOI] [PubMed] [Google Scholar]
  10. Dörk T., Dworniczak B., Aulehla-Scholz C., Wieczorek D., Böhm I., Mayerova A., Seydewitz H. H., Nieschlag E., Meschede D., Horst J. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet. 1997 Sep;100(3-4):365–377. doi: 10.1007/s004390050518. [DOI] [PubMed] [Google Scholar]
  11. Gan K. H., Veeze H. J., van den Ouweland A. M., Halley D. J., Scheffer H., van der Hout A., Overbeek S. E., de Jongste J. C., Bakker W., Heijerman H. G. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med. 1995 Jul 13;333(2):95–99. doi: 10.1056/NEJM199507133330204. [DOI] [PubMed] [Google Scholar]
  12. Gan K. H., Veeze H. J., van den Ouweland A. M., Halley D. J., Scheffer H., van der Hout A., Overbeek S. E., de Jongste J. C., Bakker W., Heijerman H. G. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med. 1995 Jul 13;333(2):95–99. doi: 10.1056/NEJM199507133330204. [DOI] [PubMed] [Google Scholar]
  13. Garred P., Madsen H. O., Hofmann B., Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet. 1995 Oct 7;346(8980):941–943. doi: 10.1016/s0140-6736(95)91559-1. [DOI] [PubMed] [Google Scholar]
  14. Garred P., Pressler T., Madsen H. O., Frederiksen B., Svejgaard A., Høiby N., Schwartz M., Koch C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest. 1999 Aug;104(4):431–437. doi: 10.1172/JCI6861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Girodon E., Cazeneuve C., Lebargy F., Chinet T., Costes B., Ghanem N., Martin J., Lemay S., Scheid P., Housset B. CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet. 1997 May-Jun;5(3):149–155. [PubMed] [Google Scholar]
  16. Goldstein J. L., Shapiro A. B., Rao M. C., Layden T. J. In vivo evidence of altered chloride but not potassium secretion in cystic fibrosis rectal mucosa. Gastroenterology. 1991 Oct;101(4):1012–1019. doi: 10.1016/0016-5085(91)90728-4. [DOI] [PubMed] [Google Scholar]
  17. Groman Joshua D., Meyer Michelle E., Wilmott Robert W., Zeitlin Pamela L., Cutting Garry R. Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med. 2002 Aug 8;347(6):401–407. doi: 10.1056/NEJMoa011899. [DOI] [PubMed] [Google Scholar]
  18. Hiatt P. W., Grace S. C., Kozinetz C. A., Raboudi S. H., Treece D. G., Taber L. H., Piedra P. A. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics. 1999 Mar;103(3):619–626. doi: 10.1542/peds.103.3.619. [DOI] [PubMed] [Google Scholar]
  19. Hull J., Thomson A. H. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax. 1998 Dec;53(12):1018–1021. doi: 10.1136/thx.53.12.1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kerem E., Corey M., Kerem B. S., Rommens J., Markiewicz D., Levison H., Tsui L. C., Durie P. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med. 1990 Nov 29;323(22):1517–1522. doi: 10.1056/NEJM199011293232203. [DOI] [PubMed] [Google Scholar]
  21. Knowles Michael R., Durie Peter R. What is cystic fibrosis? N Engl J Med. 2002 Aug 8;347(6):439–442. doi: 10.1056/NEJMe020070. [DOI] [PubMed] [Google Scholar]
  22. Kosorok M. R., Zeng L., West S. E., Rock M. J., Splaingard M. L., Laxova A., Green C. G., Collins J., Farrell P. M. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001 Oct;32(4):277–287. doi: 10.1002/ppul.2009.abs. [DOI] [PubMed] [Google Scholar]
  23. Littlewood J. M. The sweat test. Arch Dis Child. 1986 Nov;61(11):1041–1043. doi: 10.1136/adc.61.11.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Massie J., Robinson P. Cystic fibrosis: the twilight zone. Pediatr Pulmonol. 1999 Sep;28(3):222–224. doi: 10.1002/(sici)1099-0496(199909)28:3<222::aid-ppul10>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  25. Mekus F., Ballmann M., Bronsveld I., Bijman J., Veeze H., Tümmler B. Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res. 2000 Dec;3(4):277–293. doi: 10.1375/136905200320565256. [DOI] [PubMed] [Google Scholar]
  26. Mekus F., Ballmann M., Bronsveld I., Dörk T., Bijman J., Tümmler B., Veeze H. J. Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator. Hum Genet. 1998 May;102(5):582–586. doi: 10.1007/s004390050744. [DOI] [PubMed] [Google Scholar]
  27. Milla C. E. Allergic bronchopulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol. 1999 Feb;27(2):71–73. doi: 10.1002/(sici)1099-0496(199902)27:2<71::aid-ppul1>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  28. Miller P. W., Hamosh A., Macek M., Jr, Greenberger P. A., MacLean J., Walden S. M., Slavin R. G., Cutting G. R. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet. 1996 Jul;59(1):45–51. [PMC free article] [PubMed] [Google Scholar]
  29. Monaghan K. G., Feldman G. L., Barbarotto G. M., Manji S., Desai T. K., Snow K. Frequency and clinical significance of the S1235R mutation in the cystic fibrosis transmembrane conductance regulator gene: results from a collaborative study. Am J Med Genet. 2000 Dec 11;95(4):361–365. [PubMed] [Google Scholar]
  30. Ranganathan S. C., Dezateux C., Bush A., Carr S. B., Castle R. A., Madge S., Price J., Stroobant J., Wade A., Wallis C. Airway function in infants newly diagnosed with cystic fibrosis. Lancet. 2001 Dec 8;358(9297):1964–1965. doi: 10.1016/s0140-6736(01)06970-7. [DOI] [PubMed] [Google Scholar]
  31. Rohlfs E. M., Shaheen N. J., Silverman L. M. Is the hemochromatosis gene a modifier locus for cystic fibrosis? Genet Test. 1998;2(1):85–88. doi: 10.1089/gte.1998.2.85. [DOI] [PubMed] [Google Scholar]
  32. Rosenstein B. J., Cutting G. R. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr. 1998 Apr;132(4):589–595. doi: 10.1016/s0022-3476(98)70344-0. [DOI] [PubMed] [Google Scholar]
  33. Rosenstein Beryl J. Cystic fibrosis diagnosis: new dilemmas for an old disorder. Pediatr Pulmonol. 2002 Feb;33(2):83–84. doi: 10.1002/ppul.10053. [DOI] [PubMed] [Google Scholar]
  34. Rozmahel R., Wilschanski M., Matin A., Plyte S., Oliver M., Auerbach W., Moore A., Forstner J., Durie P., Nadeau J. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet. 1996 Mar;12(3):280–287. doi: 10.1038/ng0396-280. [DOI] [PubMed] [Google Scholar]
  35. Sharer N., Schwarz M., Malone G., Howarth A., Painter J., Super M., Braganza J. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med. 1998 Sep 3;339(10):645–652. doi: 10.1056/NEJM199809033391001. [DOI] [PubMed] [Google Scholar]
  36. Taylor M. E., Brickell P. M., Craig R. K., Summerfield J. A. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J. 1989 Sep 15;262(3):763–771. doi: 10.1042/bj2620763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wallis C. Diagnosing cystic fibrosis: blood, sweat, and tears. Arch Dis Child. 1997 Feb;76(2):85–88. doi: 10.1136/adc.76.2.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Welsh M. J., Smith A. E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993 Jul 2;73(7):1251–1254. doi: 10.1016/0092-8674(93)90353-r. [DOI] [PubMed] [Google Scholar]
  39. Wilson D. C., Ellis L., Zielenski J., Corey M., Ip W. F., Tsui L. C., Tullis E., Knowles M. R., Durie P. R. Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr. 1998 Apr;132(4):596–599. doi: 10.1016/s0022-3476(98)70345-2. [DOI] [PubMed] [Google Scholar]
  40. Zeitlin P. L. Novel pharmacologic therapies for cystic fibrosis. J Clin Invest. 1999 Feb;103(4):447–452. doi: 10.1172/JCI6346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Zielenski J., Corey M., Rozmahel R., Markiewicz D., Aznarez I., Casals T., Larriba S., Mercier B., Cutting G. R., Krebsova A. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet. 1999 Jun;22(2):128–129. doi: 10.1038/9635. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES